Kumquat Biosciences Inc.
Pioneering the development of groundbreaking cancer treatments through innovative science.
Pioneering the development of groundbreaking cancer treatments through innovative science.
Kumquat Biosciences Inc. is a pioneering biotechnology startup dedicated to the development of groundbreaking cancer treatments. Established in 2018, the company is committed to translating innovative scientific research into therapeutic solutions. With its headquarters in the United States, Kumquat Biosciences is at the forefront of drug discovery and development in the Biotechnology and Health and Wellness industries.
The company recently received a $70.00MCorporate Round investment on 29 July 2021, with Loxo Oncology as one of the lead investors. This significant investment validates the potential of Kumquat Biosciences' innovative approach to cancer treatment and signifies the confidence that key players in the industry have in the company's capabilities.
With its promising slogan, "Pioneering the development of groundbreaking cancer treatments through innovative science," and impressive recent funding, Kumquat Biosciences is poised to make a significant impact in the field of cancer therapeutics, potentially revolutionizing the way cancer is treated in the future.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Corporate Round | $70.00M | 1 | Loxo Oncology | 29 Jul 2021 |
| Funding Round | $50.00M | - | 16 Feb 2021 | |
| Private Equity Round | $55.92M | - | 02 Jul 2019 |
No recent news or press coverage available for Kumquat Biosciences Inc..
We care about your data, and we'd love to use cookies make your experience better.
